Withdrawal from familial ovarian cancer screening for surgery: Findings from a psychological evaluation study (PsyFOCS)

Kate J. Lifford; Lindsay Fraser; Adam N. Rosenthal; Mark T. Rogers; Deborah Lancastle; Ceri Phelps; Eila K. Watson; Alison Clements; Rachel Iredale; Ian Jacobs; Usha Menon; Kate E. Brain

doi:10.1016/j.ygyno.2011.09.015

Withdrawal from familial ovarian cancer screening for surgery: Findings from a psychological evaluation study (PsyFOCS)

Kate J. Lifford, Lindsay Fraser, Adam N. Rosenthal, Mark T. Rogers, Deborah Lancastle, Ceri Phelps, Eila K. Watson, Alison Clements, Rachel Iredale, Ian Jacobs, Usha Menon, Kate E. Brain

Research output: Contribution to journal › Article › peer-review

Abstract

Objective: A prospective psychological evaluation study of familial ovarian cancer screening (PsyFOCS) is underway in partnership with the UK Familial Ovarian Cancer Screening Study (UK FOCSS Phase 2). One of the aims of PsyFOCS is to examine factors associated with withdrawal from the UK FOCSS prior to the onset of 4-monthly screening. Method: 1999 of 3224 women completed a baseline questionnaire. 110 (5.5%) women withdrew from screening prior to their first routine Phase 2 screen, of which 73 (66.4% of withdrawals) had withdrawn because they had undergone removal of their ovaries and fallopian tubes (withdrawn group). The comparison group consisted of 1868 women who remained on screening. The baseline questionnaire included measures of cancer-specific distress, anxiety, depression and illness perceptions. Results: Logistic regression analysis indicated that having had prior annual (Phase 1) screening (OR = 13.34, p

Original language	English
Pages (from-to)	158-163
Number of pages	5
Journal	Gynecologic Oncology
Volume	124
Issue number	1
DOIs	https://doi.org/10.1016/j.ygyno.2011.09.015
Publication status	Published - Jan 2012

Keywords

Cancer-specific distress
Familial cancer
Ovarian cancer
Ovarian cancer screening
Risk-reducing salpingo-oophorectomy
Withdrawal from screening

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ygyno.2011.09.015

Cite this

Lifford, K. J., Fraser, L., Rosenthal, A. N., Rogers, M. T., Lancastle, D., Phelps, C., Watson, E. K., Clements, A., Iredale, R., Jacobs, I., Menon, U., & Brain, K. E. (2012). Withdrawal from familial ovarian cancer screening for surgery: Findings from a psychological evaluation study (PsyFOCS). Gynecologic Oncology, 124(1), 158-163. https://doi.org/10.1016/j.ygyno.2011.09.015

@article{f1344bcb98004240895e5df12c204f5f,

title = "Withdrawal from familial ovarian cancer screening for surgery: Findings from a psychological evaluation study (PsyFOCS)",

abstract = "Objective: A prospective psychological evaluation study of familial ovarian cancer screening (PsyFOCS) is underway in partnership with the UK Familial Ovarian Cancer Screening Study (UK FOCSS Phase 2). One of the aims of PsyFOCS is to examine factors associated with withdrawal from the UK FOCSS prior to the onset of 4-monthly screening. Method: 1999 of 3224 women completed a baseline questionnaire. 110 (5.5%) women withdrew from screening prior to their first routine Phase 2 screen, of which 73 (66.4% of withdrawals) had withdrawn because they had undergone removal of their ovaries and fallopian tubes (withdrawn group). The comparison group consisted of 1868 women who remained on screening. The baseline questionnaire included measures of cancer-specific distress, anxiety, depression and illness perceptions. Results: Logistic regression analysis indicated that having had prior annual (Phase 1) screening (OR = 13.34, p",

keywords = "Cancer-specific distress, Familial cancer, Ovarian cancer, Ovarian cancer screening, Risk-reducing salpingo-oophorectomy, Withdrawal from screening",

author = "Lifford, {Kate J.} and Lindsay Fraser and Rosenthal, {Adam N.} and Rogers, {Mark T.} and Deborah Lancastle and Ceri Phelps and Watson, {Eila K.} and Alison Clements and Rachel Iredale and Ian Jacobs and Usha Menon and Brain, {Kate E.}",

year = "2012",

month = jan,

doi = "10.1016/j.ygyno.2011.09.015",

language = "English",

volume = "124",

pages = "158--163",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Elsevier BV",

number = "1",

}

TY - JOUR

T1 - Withdrawal from familial ovarian cancer screening for surgery: Findings from a psychological evaluation study (PsyFOCS)

AU - Lifford, Kate J.

AU - Fraser, Lindsay

AU - Rosenthal, Adam N.

AU - Rogers, Mark T.

AU - Lancastle, Deborah

AU - Phelps, Ceri

AU - Watson, Eila K.

AU - Clements, Alison

AU - Iredale, Rachel

AU - Jacobs, Ian

AU - Menon, Usha

AU - Brain, Kate E.

PY - 2012/1

Y1 - 2012/1

N2 - Objective: A prospective psychological evaluation study of familial ovarian cancer screening (PsyFOCS) is underway in partnership with the UK Familial Ovarian Cancer Screening Study (UK FOCSS Phase 2). One of the aims of PsyFOCS is to examine factors associated with withdrawal from the UK FOCSS prior to the onset of 4-monthly screening. Method: 1999 of 3224 women completed a baseline questionnaire. 110 (5.5%) women withdrew from screening prior to their first routine Phase 2 screen, of which 73 (66.4% of withdrawals) had withdrawn because they had undergone removal of their ovaries and fallopian tubes (withdrawn group). The comparison group consisted of 1868 women who remained on screening. The baseline questionnaire included measures of cancer-specific distress, anxiety, depression and illness perceptions. Results: Logistic regression analysis indicated that having had prior annual (Phase 1) screening (OR = 13.34, p

AB - Objective: A prospective psychological evaluation study of familial ovarian cancer screening (PsyFOCS) is underway in partnership with the UK Familial Ovarian Cancer Screening Study (UK FOCSS Phase 2). One of the aims of PsyFOCS is to examine factors associated with withdrawal from the UK FOCSS prior to the onset of 4-monthly screening. Method: 1999 of 3224 women completed a baseline questionnaire. 110 (5.5%) women withdrew from screening prior to their first routine Phase 2 screen, of which 73 (66.4% of withdrawals) had withdrawn because they had undergone removal of their ovaries and fallopian tubes (withdrawn group). The comparison group consisted of 1868 women who remained on screening. The baseline questionnaire included measures of cancer-specific distress, anxiety, depression and illness perceptions. Results: Logistic regression analysis indicated that having had prior annual (Phase 1) screening (OR = 13.34, p

KW - Cancer-specific distress

KW - Familial cancer

KW - Ovarian cancer

KW - Ovarian cancer screening

KW - Risk-reducing salpingo-oophorectomy

KW - Withdrawal from screening

U2 - 10.1016/j.ygyno.2011.09.015

DO - 10.1016/j.ygyno.2011.09.015

M3 - Article

C2 - 21999920

SN - 0090-8258

VL - 124

SP - 158

EP - 163

JO - Gynecologic Oncology

JF - Gynecologic Oncology

IS - 1

ER -

Withdrawal from familial ovarian cancer screening for surgery: Findings from a psychological evaluation study (PsyFOCS)

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this